Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Bodilsen

Showing results (141-150 of 146) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 146 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2021
Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort StudyThomas Benfield, Jacob Bodilsen, Christian Brieghel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 23, 2022
Correction to: Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort StudyThomas Benfield, Jacob Bodilsen, Christian Brieghel, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 14, 2022
Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: the Danish Nationwide ENFORCE StudyOle Schmeltz Søgaard, Joanne Reekie, Isik Somuncu Johansen, et al.
Communications Medicine|April 24, 2023
Impact of age and comorbidities on SARS-CoV-2 vaccine-induced T cell immunityLisa Loksø Dietz, Anna Karina Juhl, Ole Schmeltz Søgaard, et al.
Eclinicalmedicine|April 27, 2021
Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trialJesper D Gunst, Nina B Staerke, Marie H Pahus, et al.
Brain : a Journal of Neurology|June 18, 2026
Long-term prognosis of patients surviving progressive multifocal leukoencephalopathyNicolas Lambert, Majdouline El Moussaoui, Adèle Le Guilloux, et al.
Pageof 15

Showing results (141-150 of 146) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 146 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2021
Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort StudyThomas Benfield, Jacob Bodilsen, Christian Brieghel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 23, 2022
Correction to: Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort StudyThomas Benfield, Jacob Bodilsen, Christian Brieghel, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 14, 2022
Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: the Danish Nationwide ENFORCE StudyOle Schmeltz Søgaard, Joanne Reekie, Isik Somuncu Johansen, et al.
Communications Medicine|April 24, 2023
Impact of age and comorbidities on SARS-CoV-2 vaccine-induced T cell immunityLisa Loksø Dietz, Anna Karina Juhl, Ole Schmeltz Søgaard, et al.
Eclinicalmedicine|April 27, 2021
Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trialJesper D Gunst, Nina B Staerke, Marie H Pahus, et al.
Brain : a Journal of Neurology|June 18, 2026
Long-term prognosis of patients surviving progressive multifocal leukoencephalopathyNicolas Lambert, Majdouline El Moussaoui, Adèle Le Guilloux, et al.
Pageof 15